Evidence map›Paper›PMID 26377466›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2015

Impaired Cholinergic Excitation of Prefrontal Attention Circuitry in the TgCRND8 Model of Alzheimer's Disease.

Éliane Proulx, Paul Fraser, JoAnne McLaurin, Evelyn K Lambe

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. AmyloidInternational journal of peptides · 2017
    Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 4 countries.

Éliane ProulxDepartments of Physiology.
Paul FraserMedical Biophysics, Tanz Centre for Research in Neurodegenerative Diseases, and.
JoAnne McLaurinLaboratory Medicine and Pathobiology, Biological Sciences, Sunnybrook Research Institute, University of Toronto, Toronto, Ontario M5S 1A8, Canada.
Evelyn K LambeDepartments of Physiology, Obstetrics and Gynaecology, Psychiatry, and evelyn.lambe@utoronto.ca.ORCID http://orcid.org/0000-0002-5994-6090
Czech Academy of Sciences, Institute of Physiology · CZGerman Center for Neurodegenerative Diseases · DELaboratoire Analyse et Modélisation pour la Biologie et l'Environnement · FRSunnybrook Health Science Centre · CA

Funding

CIHR 83422-2CIHR 89825-2CIHR MOP-102467CIHR MOP-89825CIHR TAD-117950
6 · The paper itself

Abstract

Attention deficits in Alzheimer's disease can exacerbate its other cognitive symptoms, yet relevant disruptions of key prefrontal circuitry are not well understood. Here, in the TgCRND8 mouse model of this neurological disorder, we demonstrate and characterize a disruption of cholinergic excitation in the major corticothalamic layer of the prefrontal cortex, in which modulation by acetylcholine is essential for optimal attentional function. Using electrophysiology with concurrent multiphoton imaging, we show that layer 6 pyramidal cells are unable to sustain cholinergic excitation to the same extent as their nontransgenic littermate controls, as a result of the excessive activation of calcium-activated hyperpolarizing conductances. We report that cholinergic excitation can be improved in TgCRND8 cortex by pharmacological blockade of SK channels, suggesting a novel target for the treatment of cognitive dysfunction in Alzheimer's disease. SIGNIFICANCE STATEMENT: Alzheimer's disease is accompanied by attention deficits that exacerbate its other cognitive symptoms. In brain slices of a mouse model of this neurological disorder, we demonstrate, characterize, and rescue impaired cholinergic excitation of neurons essential for optimal attentional performance. In particular, we show that the excessive activation of a calcium-activated potassium conductance disrupts the acetylcholine excitation of prefrontal layer 6 pyramidal neurons and that its blockade normalizes responses. These findings point to a novel potential target for the treatment of cognitive dysfunction in Alzheimer's disease.

Indexed as

AcetylcholineAction PotentialsAlzheimer DiseaseAmyloid beta-Protein PrecursorAnimalsApaminAtropineAttentionCalcium SignalingCholinergic NeuronsDisease Models, AnimalFemaleGenotypeIon Channel GatingMaleMiceAcetylcholineAmyloid beta-Protein PrecursorApaminAtropineNerve Tissue ProteinsSmall-Conductance Calcium-Activated Potassium Channelsacetylcholine receptorsafterhyperpolarization potential (AHP)Alzheimer's modelcorticothalamicprefrontal cortexSK channels

Identifiers

PMID26377466
PMCPMC4640899
OpenAlexW1472652818

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.